跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
宋 立勤
副教授
,
心臟血管內科
成員
,
臺北醫學大學臺北心臟醫學研究中心
成員
,
臺北醫學大學泌尿腎臟研究中心
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0001-6292-7117
電子郵件
10204
s.tmu.edu
tw
h-index
618
引文
16
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2024
每年研究成果
概覽
指紋
網路
專案
(5)
研究成果
(65)
資料集
(4)
類似的個人檔案
(6)
指紋
查看啟用 Li-Chin Sung 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Influenza Vaccination
63%
Cohort Analysis
60%
Medicine
54%
Chronic Kidney Disease
46%
Acute Heart Infarction
40%
Hazard Ratio
40%
4 Iodo 2,5 Dimethoxyamphetamine
36%
Elderly Patient
32%
Cardiogenic Shock
30%
Odds Ratio
30%
Cardiovascular Disease
28%
Vascular Endothelial Cell
27%
Cafestol
27%
Extracorporeal Membrane Oxygenation
27%
Monocyte Chemotactic Protein 1
27%
Percutaneous Coronary Intervention
27%
Artery
27%
Interleukin 8
27%
Internal Medicine
26%
Hemodialysis
25%
Atrial Fibrillation
22%
Cell Proliferation
22%
Division
22%
Apoplexy
22%
Heart Failure
21%
Revascularization
20%
ST Segment Elevation Myocardial Infarction
19%
Retrospective Cohort Study
18%
Case-Control Study
18%
Noncardiac Surgery
18%
Randomized Controlled Trial
18%
Antiplatelet Drug
18%
Coronary Artery Dissection
18%
Collagen Synthesis
18%
Arteriovenous Fistula
18%
Fibroblast
18%
Intercellular Adhesion Molecule 1
18%
Computerized Physician Order Entry
18%
Cardiology
17%
Renal Replacement Therapy
16%
Blood Pressure
16%
Right Coronary Artery
16%
Secretion (Process)
14%
Patient History of Coronary Artery Bypass Graft
13%
Major Adverse Cardiac Event
12%
Coronary Angiography
12%
Acute Coronary Syndrome
12%
Septicemia
11%
Shock (Circulatory)
10%
End Stage Renal Disease
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Chronic Kidney Failure
74%
Vaccination Policy
72%
Chronic Obstructive Lung Disease
45%
Cardiovascular Disease
43%
Nicorandil
36%
Statin (Protein)
32%
Transcription Factor Nrf2
27%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
27%
Cafestol
27%
Interleukin 8
27%
Urotensin II
27%
Heme Oxygenase 1
23%
Adverse Outcome
22%
Diabetes Mellitus
21%
Reactive Oxygen Metabolite
21%
Acute Coronary Syndrome
21%
Endothelin 1
19%
Heart Failure
19%
Comorbidity
18%
Monocyte Chemotactic Protein 1
18%
Lycopene
18%
Acute Heart Infarction
18%
Hemodialysis
18%
Atrial Fibrillation
18%
Malignant Neoplasm
16%
Dyslipidemia
14%
All Cause Mortality
14%
Peripheral Occlusive Artery Disease
13%
End Stage Renal Disease
12%
Major Adverse Cardiac Event
12%
Activating Transcription Factor 3
12%
Mevinolin
11%
Inflammasome
11%
Diuretic Agent
11%
Momordica Charantia
10%
Brain Hemorrhage
10%
Virtual Screening
10%
Diterpene
9%
Brain Ischemia
9%
Doxorubicin
9%
Antilipemic Agent
9%
Coronary Artery Spasm
9%
Bungarotoxin Receptor
9%
Antithrombocytic Agent
9%
Red Yeast Rice
9%
Lung Cancer
9%
Non Insulin Dependent Diabetes Mellitus
9%
Bruton Tyrosine Kinase Inhibitor
9%
Lipopolysaccharide
9%
Nursing and Health Professions
Influenza Vaccination
45%
Cohort Analysis
43%
Confidence Interval
31%
Elderly Patient
27%
Hazard Ratio
22%
Adverse Outcome
18%
Rheumatoid Arthritis
18%
Cross-Sectional Study
18%
Chronic Kidney Failure
18%
Acute Coronary Syndrome
18%
Heart Failure
18%
Obstructive Lung Disease
18%
Odds Ratio
17%
Diabetes Mellitus
15%
Atrial Fibrillation
13%
Vaccination Policy
12%
Cardiovascular Disease
11%
Septicemia
10%
Brain Ischemia
9%
Chronic Pancreatitis
9%
CHA2DS2-VASc Score
9%
School Health Service
9%
Metabolic Syndrome X
9%
Patient with Type 2 Diabetes
9%
Coronary Artery Atherosclerosis
9%
Dental Scaling
9%
Antilipemic Agent
9%
Eye Disease
9%
Dry Eye
9%
Dyslipidemia
9%
Acute Pancreatitis
9%
Renal Replacement Therapy
9%
Proportional Hazards Model
7%
Statin (Protein)
7%
National Health Insurance
6%
Propensity Score
5%
